Join Date
October 2024
Country
Gender
Not Specified
Age
Not Specified
About Nick Damiano
3x medtech founder; Co-founder & CEO @ Andromeda Surgical S23;
Co-founder & CEO @ Zenflow W15 - treated > 300 patients, raised ~$70M;
Co-founder & CTO @ Avail MedSystems (f.k.a. Nurep, acq. by Mendaera) - unicorn YC reject;
Venture Partner @ Pioneer Fund;
Stanford Biodesign Innovation Fellow & Stanford MS/BS;
Biomedical/software engineer;
Dad to two girls, first YC app ETA for them around 2040;
Semicolon enthusiast;
Co-founder & CEO @ Zenflow W15 - treated > 300 patients, raised ~$70M;
Co-founder & CTO @ Avail MedSystems (f.k.a. Nurep, acq. by Mendaera) - unicorn YC reject;
Venture Partner @ Pioneer Fund;
Stanford Biodesign Innovation Fellow & Stanford MS/BS;
Biomedical/software engineer;
Dad to two girls, first YC app ETA for them around 2040;
Semicolon enthusiast;
Companies & Work
Andromeda Surgical
We're building autonomous robots to make surgery safe, easier and more efficient. Robots currently perform about 1/4 of surgeries but only help with the physical aspects. We use AI to make surgery cognitively easier. This has far greater potential to improve outcomes and reduce costs. Founded by 3x founders from medtech and autonomous vehicles, we're on track to be the fastest surgical robot to market of all time. First indication is prostate enucleation.
